Ghent University Academic Bibliography

Journal Article
A1
open access

The prognostic value of IKZF1(plus) in B‐cell progenitor acute lymphoblastic leukemia : results from the EORTC 58951 trial

Michal Kicinski, Chloé Arfeuille, Nathalie Grardel, Marleen Bakkus, Aurélie Caye‐Eude, Geneviève Plat, Alina Ferster, Anne Uyttebroeck, Barbara De Moerloose (UGent) , Pierre Rohrlich, et al.

(2023) PEDIATRIC BLOOD & CANCER. 70(6).

Add to list

Conference Paper
C3
open access

Drug response profiling informs personalized bridging to cell therapy for patients with relapsed/refractory acute lymphoblastic leukemia

Fabio D. Steffen, Andrej Lissat, Julia Alten, Cornelia Eckert, Bodmer Nicole, Thorhauge Als-Nielsen Bodil E., Adriana Balduzzi, Sarah Elitzur, Andras Kriston, Gergely Nyiri, et al.

(2023) 65th ASH Annual Meeting and Exposition, Abstracts.

Add to list

Journal Article
A1
open access

CircRNAs dysregulated in juvenile myelomonocytic leukemia : CircMCTP1 stands out

Anna Dal Molin, Mattias Hofmans (UGent) , Enrico Gaffo, Alessia Buratin, Hélène Cavé, Christian Flotho, Valerie de Haas, Charlotte M. Niemeyer, Jan Stary, Pieter Van Vlierberghe (UGent) , et al.

(2021) FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY. 8.

Add to list

Journal Article
A1
open access

Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia

Mattias Hofmans (UGent) , Tim Lammens (UGent) , Barbara Depreter, Ying Wu, Miriam Erlacher, Aurélie Caye, Hélène Cavé, Christian Flotho, Valerie de Haas, Charlotte M. Niemeyer, et al.

(2021) SCIENTIFIC REPORTS. 11(1).

Add to list

Journal Article
A1
open access

Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study

Judith M. Boer, Maria Grazia Valsecchi, Femke M. Hormann, Željko Antić, Marketa Zaliova, Claire Schwab, Giovanni Cazzaniga, Chloé Arfeuille, Hélène Cavé, Andishe Attarbaschi, et al.

(2021) LEUKEMIA. 35(10). p.2978-2982

Add to list

Pediatric randomized trial EORTC CLG 58951 : outcome for adolescent population with acute lymphoblastic leukemia

Laura Olivier-Gougenheim, Chloe Arfeuille, Stefan Suciu, Nicolas Sirvent, Genevieve Plat, Alina Ferster, Barbara De Moerloose (UGent) , Carine Domenech, Anne Uyttebroeck, Pierre-Simon Rohrlich, et al.

(2020) HEMATOLOGICAL ONCOLOGY. 38(5). p.763-772

Add to list

Conference Paper
C3
open access

NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia : a good prognostic subtype identified in a collaborative international study

Judith M. Boer, Maria Grazia Valsecchi, Femke M. Hormann, Zeljko Antic, Marketa Zaliova, Claire Schwab, Giovanni Cazzaniga, Chloe Arfeuille, Helene Cave, Andishe Attarbaschi, et al.

(2020) BLOOD. 136(Supplement 1).

Add to list

Results of successive EORTC-CLG 58 881 and 58 951 trials in paediatric T-cell acute lymphoblastic leukaemia (ALL)

Mattias Hofmans (UGent) , Stefan Suciu, Alina Ferster, Pieter Van Vlierberghe (UGent) , Françoise Mazingue, Nicolas Sirvent, Vitor Costa, Karima Yakouben, Catherine Paillard, Anne Uyttebroeck, et al.

(2019) BRITISH JOURNAL OF HAEMATOLOGY. 186(5). p.741-753

Add to list

Genetic characterization and therapeutic targeting of MYC-rearranged T cell acute lymphoblastic leukaemia

Gloria Milani (UGent) , Filip Matthijssens (UGent) , Wouter Van Loocke (UGent) , Kaat Durinck (UGent) , Juliette Roels (UGent) , Sofie Peirs (UGent) , Morgan Thénoz (UGent) , Tim Pieters (UGent) , Lindy Reunes (UGent) , Béatrice Lintermans (UGent) , et al.

(2019) BRITISH JOURNAL OF HAEMATOLOGY. 185(1). p.169-174

Add to list

Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia : proof of concept study

Mattias Hofmans (UGent) , Barbara Depreter, Tim Lammens (UGent) , Helene Cave, Christian Flotho, Henrik Hasle, Valerie de Haas, Charlotte M. Niemeyer, Jan Stary, Pieter Van Vlierberghe (UGent) , et al.

(2019) BLOOD. 134(Supplement 1). p.1701-1701

Add to list

Journal Article
A1
open access

The long non-coding RNA landscape in juvenile myelomonocytic leukemia

Mattias Hofmans (UGent) , Tim Lammens (UGent) , Hetty Helsmoortel (UGent) , Silvia Bresolin, Hélène Cavé, Christian Flotho, Henrik Hasle, Marry M van den Heuvel-Eibrink, Charlotte Niemeyer, Jan Stary, et al.

(2018) HAEMATOLOGICA. 103(11). p.e501-e504

Add to list

Journal Article
A1
open access

Prolonged versus standard native E-coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma : final results of the EORTC-CLG randomized phase III trial 58951

Veerle Mondelaers (UGent) , Stefan Suciu, Barbara De Moerloose (UGent) , Alina Ferster, Francoise Mazingue, Geneviève Plat, Karima Yakouben, Anne Uyttebroeck, Patrick Lutz, Vitor Costa, et al.

(2017) HAEMATOLOGICA. 102(10). p.1727-1738

Add to list

LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia

Hetty Helsmoortel (UGent) , Silvia Bresolin, Tim Lammens (UGent) , Hélène Cavé, Peter Noellke, Aurélie Caye, Farzaneh Ghazavi (UGent) , Andrica de Vries, Henrik Hasle, Veerle Labarque, et al.

(2016) BLOOD. 127(9). p.1163-1172

Add to list

Different outcome of T cell acute lymphoblastic leukemia with translocation t(11;14) treated in two consecutive children leukemia group EORTC trials

Pauline Simon, Stefan Suciu, Emmanuelle Clappier, Hélène Cave, Nicolas Sirvent, Geneviève Plat, Antoine Thyss, Françoise Mechinaud, Vitor M Costa, Alina Ferster, et al.

(2016) ANNALS OF HEMATOLOGY. 95(1). p.93-103

Add to list

LIN28B is over-expressed in specific subtypes of pediatric leukemia and regulates lncRNA H19

Hetty Helsmoortel (UGent) , Barbara De Moerloose (UGent) , Tim Pieters (UGent) , Farzaneh Ghazavi (UGent) , Silvia Bresolin, Helene Cave, Andrica de Vries, Valerie de Haas, Christian Flotho, Veerle Labarque, et al.

(2016) HAEMATOLOGICA. 101(6). p.E240-E244

Academic Bibliography

The prognostic value of IKZF1(plus) in B‐cell progenitor acute lymphoblastic leukemia : results from the EORTC 58951 trial

Drug response profiling informs personalized bridging to cell therapy for patients with relapsed/refractory acute lymphoblastic leukemia

CircRNAs dysregulated in juvenile myelomonocytic leukemia : CircMCTP1 stands out

Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia

Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study

Pediatric randomized trial EORTC CLG 58951 : outcome for adolescent population with acute lymphoblastic leukemia

NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia : a good prognostic subtype identified in a collaborative international study

Results of successive EORTC-CLG 58 881 and 58 951 trials in paediatric T-cell acute lymphoblastic leukaemia (ALL)

Genetic characterization and therapeutic targeting of MYC-rearranged T cell acute lymphoblastic leukaemia

Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia : proof of concept study

The long non-coding RNA landscape in juvenile myelomonocytic leukemia

Prolonged versus standard native E-coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma : final results of the EORTC-CLG randomized phase III trial 58951

LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia

Different outcome of T cell acute lymphoblastic leukemia with translocation t(11;14) treated in two consecutive children leukemia group EORTC trials

LIN28B is over-expressed in specific subtypes of pediatric leukemia and regulates lncRNA H19

Contents

Support

Contact